The Angeles Clinic and Research Institute- A Cedars-Sinai Affiliate

Los Angeles, California 90025

4 studies enrolling now · 11 studies all time

What they study most

Advanced Cancer, Advanced Solid Tumors, Advanced or Metastatic Solid Tumors, Brain Metastases, Brain Neoplasms, Differentiated Thyroid Cancer, Glioma, HGG, High Grade Glioma, LGG, Low Grade Glioma, Lymphoma, Non-Hodgkin

Studies at this site

• A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors — Recruiting now
• TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer — Recruiting now
• Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors — Recruiting now
• SNV4818 in Participants With Advanced Solid Tumors — Recruiting now
• Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors — Completed
• Study to Test the Safety and Tolerability of PF-07257876 in Participants With Selected Advanced Tumors. — Completed
• A Study to Learn About the Study Medicine Called PF-08046031 in Advanced Melanoma and Other Solid Tumors — Stopped early
• Phase IIB TL + YCWP + DC in Melanoma — Completed
• A Study of BMS-986406 as Monotherapy and Combination Therapies in Participants With Advanced Tumors — Completed
• An Open-Label, Randomized, Multicenter Trial of Encorafenib + Binimetinib Evaluating a Standard-dose and a High-dose Regimen in Patients With BRAFV600-mutant Melanoma Brain Metastasis — Stopped early
• Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566 — Completed